Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Roivant Enters $95 Million Deal for China Rights to Novel Antibiotic

publication date: Mar 29, 2018

Roivant Sciences, a US in-licensing company, acquired greater China rights to a clinical-stage antibiotic for community-acquired bacterial pneumonia (CABP) from Nabriva Therapeutics in a $95 million deal. Roivant paid $5 million upfront and will make up to $90 million in milestone payments, plus royalties. Nabriva reported positive data from one international Phase III trial of lefamulin last year, and it expects results from a second Phase III trial this Spring. Roivant will be responsible for clinical and registrational costs in China, Taiwan, Hong Kong and Macau. More details....

Stock Symbol: (NSDQ: NBRV)

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here